Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1989-12-20
1992-11-17
Cashion, Jr., Merrell C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
530303, 435 694, C07K 740, A61K 3726
Patent
active
051643669
ABSTRACT:
The present invention relates to novel human insulin analogues exhibiting a low ability to associate in solution, a method for the preparation of such insulin analogues, insulin preparations containing the human insulin analogues of the invention and a method of treating Diabetes Mellitus using these human insulin analogues.
REFERENCES:
patent: 3903069 (1975-09-01), Geregory
patent: 4320196 (1982-03-01), Morihara et al.
patent: 4701440 (1987-10-01), Grau
Frank, B., "Self-Assocation and Confermational Studies on Human Poinsulin and Insulin Analogs", Abstract, Conference on Insulin, 1989.
Chance, R., "Preparation of a New Series of Insulin Analogs", Conference on Insulin, Sep. 1989.
Nakagawa, S. et al., Journal of Biological Chemistry, 262(25): 12054-58, Sep. 1987.
Balschmidt Per
Brange Jens J. V.
Cashion Jr. Merrell C.
Novo Nordisk A S
Perkins Susan M.
Zelson Steve T.
LandOfFree
Human insulin analogues does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Human insulin analogues, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human insulin analogues will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1172105